Literature DB >> 7579475

Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases.

D Roulston, J Anastasi, R Rudinsky, G Nucifora, N Zeleznik-Le, J D Rowley, L McGavran, M Tsuchida, Y Hayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7579475

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

Review 1.  Targeting DNA topoisomerase II in cancer chemotherapy.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

2.  MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).

Authors:  O M Sobulo; J Borrow; R Tomek; S Reshmi; A Harden; B Schlegelberger; D Housman; N A Doggett; J D Rowley; N J Zeleznik-Le
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

3.  Polymorphisms in the MLL breakpoint cluster region (BCR).

Authors:  Deborah R Echlin-Bell; Lydia L Smith; Loretta Li; Pamela L Strissel; Reiner Strick; Vandana Gupta; Jhula Banerjee; Richard Larson; Mary V Relling; Susan C Raimondi; Yasuhide Hayashi; Tomohiko Taki; Nancy Zeleznik-Le; Janet D Rowley
Journal:  Hum Genet       Date:  2003-03-29       Impact factor: 4.132

4.  Cracking the cytotoxicity code: apoptotic induction of 10-acetylirciformonin B is mediated through ROS generation and mitochondrial dysfunction.

Authors:  Huei-Chuan Shih; Mohamed El-Shazly; Yung-Shun Juan; Chao-Yuan Chang; Jui-Hsin Su; Yu-Cheng Chen; Shou-Ping Shih; Huei-Mei Chen; Yang-Chang Wu; Mei-Chin Lu
Journal:  Mar Drugs       Date:  2014-05-22       Impact factor: 5.118

5.  At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.

Authors:  Chezi Ganzel; Xin V Wang; Jacob M Rowe; Susan M Richards; Georgina Buck; David I Marks; Mark R Litzow; Elisabeth M Paietta; Letizia Foroni; Selina M Luger; Cheryl L Willman; Charles G Mullighan; Kathryn G Roberts; Peter H Wiernik; Dan Douer; Hillard M Lazarus; Martin S Tallman; Anthony H Goldstone
Journal:  Br J Haematol       Date:  2020-03-27       Impact factor: 6.998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.